(Q39240611)
Statements
1 reference
A phase 2 study evaluating the efficacy and safety of a novel, proprietary, nano-formulated, lower dose oral diclofenac (English)
1 reference
Garen Manvelian
1 reference
Stephen Daniels
1 reference
Allan Gibofsky
1 reference
8 October 2012
1 reference
1 reference
13
1 reference
11
1 reference
1491-1498
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference